Future Market Insights6m
Global Major Depressive Disorder (MDD) Treatment Market Projected to Reach USD 14.96 Billion by 2032 at a CAGR of 2.8% | FMI
The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...
Future Market Insights10m
Global Fatty Liver Treatment Market Expected to Reach USD 32.5 Billion by 2032 develop at a CAGR of 5%
The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...
Le Lézard46m
Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
MEDIA RELEASE Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One of several biosimilar value drivers for SandozSandoz ...